UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 3.932

Sortiert nach

Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients

Journal of thrombosis and haemostasis, 2018-03, Vol.16 (3), p.508-518

2018

Link zum Volltext

Verfügbarkeit prüfen

Treatment of cancer-associated venous thromboembolism in the age of direct oral anticoagulants

Annals of oncology, 2019-06, Vol.30 (6), p.897-907

2019

Link zum Volltext

Verfügbarkeit prüfen

Venous thromboembolism in cancer patients: a population-based cohort study

Blood, 2021-04, Vol.137 (14), p.1959-1969

2021

Link zum Volltext

Verfügbarkeit prüfen

Venous thrombosis and cancer: from mouse models to clinical trials

Journal of thrombosis and haemostasis, 2015-08, Vol.13 (8), p.1372-1382

2015

Link zum Volltext

Verfügbarkeit prüfen

Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline

Annals of oncology, 2023-05, Vol.34 (5), p.452-467

2023

Link zum Volltext

Verfügbarkeit prüfen

Management of cancer‐associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2018-06, Vol.16 (6), p.1246-1249

2018

Link zum Volltext

Verfügbarkeit prüfen

Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (7), p.980-988

2018

Link zum Volltext

Verfügbarkeit prüfen

Correspondence to: Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study

Annals of oncology, 2024-03, Vol.35 (3), p.327-327

2024

Link zum Volltext

Verfügbarkeit prüfen

Combination of isocitrate dehydrogenase 1 (IDH1) mutation and podoplanin expression in brain tumors identifies patients at high or low risk of venous thromboembolism

Journal of thrombosis and haemostasis, 2018-06, Vol.16 (6), p.1121-1127

2018

Link zum Volltext

Verfügbarkeit prüfen

Human pancreatic tumors grown in mice release tissue factor‐positive microvesicles that increase venous clot size

Journal of thrombosis and haemostasis, 2017-11, Vol.15 (11), p.2208-2217

2017

Link zum Volltext

Verfügbarkeit prüfen

Microparticle‐associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients

Journal of thrombosis and haemostasis, 2012-07, Vol.10 (7), p.1363-1370

2012

Link zum Volltext

Verfügbarkeit prüfen

Occult cancer screening in patients with venous thromboembolism: guidance from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2017-10, Vol.15 (10), p.2076-2079

2017

Link zum Volltext

Verfügbarkeit prüfen

Platelets in cancer and thrombosis

Hämostaseologie, 2014-01, Vol.34 (1), p.54

2014

Link zum Volltext

Verfügbarkeit prüfen

High proportion of patients with bleeding of unknown cause in persons with a mild‐to‐moderate bleeding tendency: Results from the Vienna Bleeding Biobank (VIBB)

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-05, Vol.24 (3), p.405-413

2018

Link zum Volltext

Verfügbarkeit prüfen

Estimating risk of venous thromboembolism in patients with cancer in the presence of competing mortality

Journal of thrombosis and haemostasis, 2015-03, Vol.13 (3), p.390-397

2015

Link zum Volltext

Verfügbarkeit prüfen

Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai‐VTE study

BJOG : an international journal of obstetrics and gynaecology, 2018-11, Vol.125 (12), p.1581-1589

2018

Link zum Volltext

Verfügbarkeit prüfen

P1663: THE EFFECTS OF OBESITY ON BLEEDING FREQUENCY AND PARAMETERS OF FIBRINOLYSIS IN PATIENTS WITH NON-SEVERE HEMOPHILIA

HemaSphere, 2022-06, Vol.6 (Suppl), p.1544-1545

2022

Link zum Volltext

Verfügbarkeit prüfen

High fibrinogen levels are associated with poor survival in patients with liposarcoma

Scientific reports, 2023-05, Vol.13 (1), p.8608-8608, Article 8608

2023

Link zum Volltext

Verfügbarkeit prüfen

Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism

Blood, 2022-10, Vol.140 (16), p.1764-1773

2022

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal analysis of hemostasis biomarkers in cancer patients during antitumor treatment

Journal of thrombosis and haemostasis, 2016-02, Vol.14 (2), p.294-305

2016

Link zum Volltext

Verfügbarkeit prüfen

Decrease in microvesicle-associated tissue factor activity in morbidly obese patients after bariatric surgery

International Journal of Obesity, 2016-05, Vol.40 (5), p.768-772

2016

Link zum Volltext

Verfügbarkeit prüfen

Factor XI‐deficient mice exhibit increased bleeding after injury to the saphenous vein

Journal of thrombosis and haemostasis, 2017-09, Vol.15 (9), p.1829-1833

2017

Link zum Volltext

Verfügbarkeit prüfen

The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran

Journal of thrombosis and haemostasis, 2017-07, Vol.15 (7), p.1317-1321

2017

Link zum Volltext

Verfügbarkeit prüfen

Neurological and vascular complications of primary and secondary brain tumours: EANO-ESMO Clinical Practice Guidelines for prophylaxis, diagnosis, treatment and follow-up

Annals of oncology, 2021-02, Vol.32 (2), p.171-182

2021

Link zum Volltext

Verfügbarkeit prüfen

Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients – results from the Vienna Cancer And Thrombosis Study (CATS)

Journal of thrombosis and haemostasis, 2015-01, Vol.13 (1), p.17-22

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 3.932

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.460)
Mit Volltextzugriff
(3.519)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(3.360)
Life Sciences & Biomedicine
(1.874)
Humans
(1.254)
Physical Sciences
(1.097)
Technology
(813)
Biological And Medical Sciences
(782)
Physics
(763)
Male
(755)
Female
(730)
Medical Sciences
(571)
Animals
(556)
Adult
(428)
Exact Sciences And Technology
(391)
Middle Aged
(364)
Engineering
(351)
Physics, Applied
(348)
Aged
(278)
Materials Science
(258)
Chemistry
(252)
Engineering, Electrical & Electronic
(247)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients

Treatment of cancer-associated venous thromboembolism in the age of direct oral anticoagulants

Venous thromboembolism in cancer patients: a population-based cohort study

Venous thrombosis and cancer: from mouse models to clinical trials

Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline

Management of cancer‐associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH

Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity

Correspondence to: Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study

Combination of isocitrate dehydrogenase 1 (IDH1) mutation and podoplanin expression in brain tumors identifies patients at high or low risk of venous thromboembolism

Human pancreatic tumors grown in mice release tissue factor‐positive microvesicles that increase venous clot size

Microparticle‐associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients

Occult cancer screening in patients with venous thromboembolism: guidance from the SSC of the ISTH

Platelets in cancer and thrombosis

High proportion of patients with bleeding of unknown cause in persons with a mild‐to‐moderate bleeding tendency: Results from the Vienna Bleeding Biobank (VIBB)

Estimating risk of venous thromboembolism in patients with cancer in the presence of competing mortality

Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai‐VTE study

P1663: THE EFFECTS OF OBESITY ON BLEEDING FREQUENCY AND PARAMETERS OF FIBRINOLYSIS IN PATIENTS WITH NON-SEVERE HEMOPHILIA

High fibrinogen levels are associated with poor survival in patients with liposarcoma

Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism

Longitudinal analysis of hemostasis biomarkers in cancer patients during antitumor treatment

Decrease in microvesicle-associated tissue factor activity in morbidly obese patients after bariatric surgery

Factor XI‐deficient mice exhibit increased bleeding after injury to the saphenous vein

The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran

Neurological and vascular complications of primary and secondary brain tumours: EANO-ESMO Clinical Practice Guidelines for prophylaxis, diagnosis, treatment and follow-up

Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients – results from the Vienna Cancer And Thrombosis Study (CATS)

Suchergebnisse filtern